Literature DB >> 16514377

Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey.

Michaël Bensoussan1, Nicolas Jovenin, Bruno Garcia, Luc Vandromme, Damien Jolly, Olivier Bouché, Gérard Thiéfin, Guillaume Cadiot.   

Abstract

AIMS: Thirty to 50% of north American patients with inflammatory bowel disease (IBD) have been reported to use complementary and alternative medicine (CAM). There is no data in France. The aim of this study was to evaluate the frequency of CAM use and the reasons in a French population of patients with IBD. PATIENTS AND METHODS: An anonymous postal survey was done with a questionnaire mailed to all the patients with IBD, 16 to 79 year-old, followed-up in a public and a private medical centre of Reims, between January 2001 and December 2003.
RESULTS: The final sample included 447 patients; 325 (72.7%) filled up the questionnaire: 219 (67.4%) had Crohn's disease, 94 (28.8%) ulcerative colitis and 12 (3.7%) indeterminate colitis. Sixty-nine patients (21.2%) reported CAM use for IBD. The mean number of CAM used simultaneously was 2.9. The most frequently used CAM treatment was homeopathy (40.6%), followed by magnetism (34.8%) and acupuncture (33.3%). The majority of patients (74.8%) never talked about CAM use with their IBD physician. Multivariate analysis showed that the factors significantly associated with CAM use were female gender (odds ratio (OR)=3.5, CI95%: 1.8-6.9), the low level of confidence in their doctor (OR=4.8, CI95%: 1.1-19.8) and the research of informations about their disease (OR=4.6, CI 95%: 2.0-10.7).
CONCLUSION: Twenty-one percent of patients with IBD are using CAM, most of the time without talking about it with their physician. The quality of the relationship between the patient and his physician and female sex, more than the perceived severity of the disease, were the main determinants of that use.

Entities:  

Mesh:

Year:  2006        PMID: 16514377     DOI: 10.1016/s0399-8320(06)73072-x

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  21 in total

1.  Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.

Authors:  Réme Mountifield; Jane M Andrews; Antonina Mikocka-Walus; Peter Bampton
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 2.  Probiotics for the treatment of inflammatory bowel disease.

Authors:  Ganesh R Veerappan; John Betteridge; Patrick E Young
Journal:  Curr Gastroenterol Rep       Date:  2012-08

Review 3.  Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease.

Authors:  Stefanie Joos
Journal:  Chin J Integr Med       Date:  2011-06-10       Impact factor: 1.978

4.  Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis.

Authors:  Hideo Suzuki; Tsuyoshi Kaneko; Yuji Mizokami; Toshiaki Narasaka; Shinji Endo; Hirofumi Matsui; Akinori Yanaka; Aki Hirayama; Ichinosuke Hyodo
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

5.  Mind-body complementary alternative medicine use and quality of life in adolescents with inflammatory bowel disease.

Authors:  Sian Cotton; Yvonne Humenay Roberts; Joel Tsevat; Maria T Britto; Paul Succop; Meghan E McGrady; Michael S Yi
Journal:  Inflamm Bowel Dis       Date:  2010-03       Impact factor: 5.325

Review 6.  On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies.

Authors:  Roja Rahimi; Shilan Mozaffari; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2008-07-10       Impact factor: 3.199

7.  Homeopathic and conventional treatment for acute respiratory and ear complaints: a comparative study on outcome in the primary care setting.

Authors:  Max Haidvogl; David S Riley; Marianne Heger; Sara Brien; Miek Jong; Michael Fischer; George T Lewith; Gerard Jansen; André E Thurneysen
Journal:  BMC Complement Altern Med       Date:  2007-03-02       Impact factor: 3.659

8.  Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200.

Authors:  Nandini Bhattacharjee; Surajit Pathak; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2007-06-19       Impact factor: 2.629

9.  Qing Hua Chang Yin attenuates lipopolysaccharide-induced inflammatory response in human intestinal cells by inhibiting NF-κB activation.

Authors:  Xiao Ke; Jingtuan Chen; Xin Zhang; Wenyi Fang; Chunbo Yang; Jun Peng; Youqin Chen; Thomas J Sferra
Journal:  Exp Ther Med       Date:  2013-04-22       Impact factor: 2.447

10.  Inflammatory bowel disease professionals' attitudes to and experiences of complementary and alternative medicine.

Authors:  Annelie Lindberg; Britt Ebbeskog; Per Karlen; Lena Oxelmark
Journal:  BMC Complement Altern Med       Date:  2013-12-10       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.